# UroGen Pharma Ltd. (URGN) stock: price and valuation

URL: https://funkfolio.com/stock/URGN

> UroGen Pharma Ltd. (URGN) trades at $29.87, is worth $1.47B and scores 49/100. Valuation history, financials and signals.

---

## UroGen Pharma Ltd. (URGN)

UroGen Pharma Ltd. (URGN) is a healthcare company (biotechnology) based in the United States. The share price is $29.87, up 6.30% on the day, which values the company at $1.47B. Price as of 18 Nov 2026, 00:10 UTC, from Yahoo Finance.

### Key facts

- **Share price:** $29.87 +6.30% today
- **Market value:** $1.47B
- **Forward P/E:** 12.0×
- **Funk Score:** 49/100
- **200-week average:** $17.83 67% above
- **Sector:** Healthcare

Figures as of 18 Nov 2026, 00:10 UTC. Prices from Yahoo Finance (may be delayed); statements from company filings with the SEC and Yahoo Finance. Estimates, not advice.

### UroGen Pharma Ltd. in more detail

URGN trades at 12.0× next year's expected earnings, 5.9× sales. It sits 67% above its 200-week average of $17.83.

Over the last five fiscal years UroGen Pharma Ltd. has compounded revenue 56.2% a year. Its Funk Score is 49 out of 100 (financial strength 2.2, profitability 2.5, growth 9.9, each out of 10).

In its favour: Five straight years of revenue growth. Worth checking: Altman Z in the distress zone; Beneish M-score flags the accounts.

2 of the superinvestors tracked here hold URGN, including Polen Capital team (0.0% of the portfolio), Cathie Wood (0.0% of the portfolio).

### Superinvestors holding URGN

2 of the investors tracked here report a position in their latest 13F filing.

- [Polen Capital team Polen Capital Management](https://funkfolio.com/gurus/polen-capital) 0.02% of portfolio · $1.9M · added · Q3 2026
- [Cathie Wood ARK Invest](https://funkfolio.com/gurus/cathie-wood) 0.01% of portfolio · $2.2M · trimmed · Q3 2026

### UroGen Pharma Ltd. (URGN): questions and answers

**What is UroGen Pharma Ltd.'s market cap?**

UroGen Pharma Ltd. is valued at $1.47B at a share price of $29.87.

**Is URGN above its 200-week moving average?**

Yes. URGN is 67.5% above its 200-week average of $17.83. Long-term investors watch that line because strong companies rarely trade below it for long.

**How fast is UroGen Pharma Ltd. growing?**

Over the last five fiscal years UroGen Pharma Ltd.'s revenue grew 56.2% a year.

**Does URGN pay a dividend?**

UroGen Pharma Ltd. does not currently pay a regular dividend.

**Which famous investors own URGN?**

In their latest quarterly filings, Polen Capital team (0.0% of the portfolio), Cathie Wood (0.0% of the portfolio) hold URGN. These filings are published up to 45 days after each quarter ends, so positions may have changed since.

### Learn to read these numbers

[All stocks guides →](https://funkfolio.com/learn/stocks)

- [Altman Z-score: formula, zones and where it fails](https://funkfolio.com/learn/stocks/altman-z-score)

  The Altman Z-score is a weighted sum of five financial ratios that Edward Altman fitted in 1968 to separate companies that went bankrupt from those that did not. Funkfolio reads above 2.99 as the safe zone, below 1.81 as the distress zone, and between them a grey zone. It does not suit banks or insurers.
- [Analyst price targets and ratings: what they mean](https://funkfolio.com/learn/stocks/analyst-price-targets)

  An analyst price target is a research analyst's estimate of where a share price will be at a set horizon, such as twelve months; a rating such as buy or hold is that analyst's recommendation. A consensus is an average or median of the targets a data provider has collected. Studies have found targets on average well above later prices.
- [Free cash flow and FCF yield explained](https://funkfolio.com/learn/stocks/free-cash-flow)

  Free cash flow is the cash a business generates from operations minus what it spends on equipment, buildings and other long-lived assets. Free-cash-flow yield divides that cash by the company's market value: $5 billion of free cash flow on a $100 billion company is a 5% yield. It is cash available to owners and lenders, not profit.

### Cite this page

Funkfolio, “UroGen Pharma Ltd. (URGN) stock: price, valuation and fundamentals”, data as of 18 November 2026. https://funkfolio.com/stock/URGN

Underlying data: Yahoo Finance; company filings with the SEC.
